-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WutVOB1jSuDYNDC8veafukOdu7EX8QMhr46o+ati4ARYgmR9PuugDepw6QR2GknS 0B17U0+hTilkhNtRKZ42Wg== 0000014272-07-000146.txt : 20070601 0000014272-07-000146.hdr.sgml : 20070601 20070601123902 ACCESSION NUMBER: 0000014272-07-000146 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070524 FILED AS OF DATE: 20070601 DATE AS OF CHANGE: 20070601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zito Robert T CENTRAL INDEX KEY: 0001298694 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 07893238 BUSINESS ADDRESS: BUSINESS PHONE: 212-546-4341 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154 3 1 zit732.xml X0202 3 2007-05-24 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001298694 Zito Robert T 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 SVP & Chief Comm Officer Common Stock, $0.10 par value 26108.5 D Common Stock, $0.10 par value 767.71 I By BMY Savings & Investment Program Option (right to buy) 23.04 2014-08-01 Common Stock, $0.10 par value 40000.00 D Executive Option (right to buy) 25.45 2015-02-28 Common Stock, $0.10 par value 38667.00 D Executive Option (right to buy) 22.73 2016-03-06 Common Stock, $0.10 par value 32300.00 D Executive Option (right to buy) 24.74 2016-11-30 Common Stock, $0.10 par value 100000.00 D Executive Option (right to buy) 27.01 2017-03-05 Common Stock, $0.10 par value 39010.00 D Restricted Stock Units Common Stock, $0.10 par value 9750.00 D Includes 24,144 shares of unvested restricted stock and 503.5 shares held in a joint account with spouse. Based on a plan statement as of the end of the most recent fiscal quarter. 20,000 shares are currently exercisable. An additional 10,000 shares will become exercisable on each of August 2, 2007 and August 2, 2008. 19,333 shares are currently exercisable. An additional 9,667 shares will become exercisable on each of March 1, 2008 and March 1, 2009. 8,075 shares are currently exercisable. An additional 8,075 shares will become exercisable on each of March 7, 2008, March 7, 2009 and March 7, 2010. One-third of the options will become exercisable on each of December 1, 2009, December 1, 2010 and December 1, 2011. Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. 25% of the shares vest annually, on a cumulative basis, on March 6, 2008, March 6, 2009, March 6, 2010 and Mach 6, 2011. One-third of the restricted stock units will vest on each of March 6, 2010, March 6, 2011 and March 6, 2012 and will be converted into shares of common stock. Each restricted stock unit converts into one share of common stock upon vesting. /s/ Zito, Robert T. 2007-05-31 EX-24 2 zito.txt POWER OF ATTORNEY POWER OF ATTORNEY I, Robert T. Zito, Senior Vice President, Chief Communications Officer, of Bristol-Myers Squibb Company, a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sandra Leung, Sonia Vora and Katherine Kelly individually, as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions until such time as I am no longer an officer of Bristol-Myers Squibb Company. IN WITNESS WHEREOF, I have executed this Power of Attorney on this 31st day of May 2007. /s/ Robert T. Zito Robert T. Zito -----END PRIVACY-ENHANCED MESSAGE-----